Navigation and service

Bundesministerium für Forschung, Technologie und Raumfahrt Logo of GoBio (Link to homepage)

The view for document type GenericTable was not found.

Projects: GO-Bio (2006 bis 2025)

Tracking down the security guards of the cell: New therapeutic approach for the treatment of cardiovascular diseases : Date:

GO-Bio 2 – PD Dr. Enno Klußmann – Forschungsverbund Berlin e. V.

New active substances for activating or inhibiting AGC protein kinases : Date:

GO-Bio 2 – Dr. Ricardo M. Biondi – Goethe University Frankfurt

A biocatalysis reactor for the industrial-scale production of therapeutic siRNA molecules : Date:

GO-Bio 2 – PD Dr. med. Jacques Rohayem – Technical University Dresden | Riboxx GmbH, Radebeul

Molecular scissors for tackling HIV : Date:

GO-Bio 2 – Prof. Dr. Joachim Hauber – Department of Cell Biology and Virology, Heinrich Pette Institute (HPI) for Experimental Virology and Immunology, Hamburg

Development of a new class of drug for the prevention of organ damage in cardiac insufficiency and diabetes : Date:

GO-Bio 2 – Dr. Heiko Funke-Kaiser – Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charité University Medicine Berlin 

Development of a blood purification method for the treatment of patients with acute myocardial infarction : Date:

GO-Bio 2 – Dr. Ahmed Sheriff – Charité University Medicine Berlin, Clinic of Nephrology and Internal Intensive Care Medicine, as well as the Clinic of Cardiology, Campus Virchow Klinikum

Neuroprosthesis for the restoration of mobility in people with severe paralysis : Date:

GO-Bio 1 – Dr. Carsten Mehring – ‘Computational Motor Control & Brain-Machine Interfaces’ working group, Albert Ludwig University of Freiburg

Development of cancer drugs on the basis of highly effective small molecules : Date:

GO-Bio 1 – Joe Lewis, PhD – European Molecular Biology Laboratory (EMBL) and the German Cancer Research Center (DKFZ) at the Helmholtz Association, Heidelberg | Elara Pharmaceuticals GmbH

Development of an innovative active substance for plant protection : Date:

GO-Bio 1 – Dr. Michael Weyand – Department of Structural Biology, Max Planck Institute of Molecular Physiology, Dortmund

New therapeutic approach for the preventive treatment of atherosclerotic diseases : Date:

GO-Bio 1 – PD Dr. Dorothea Siegel-Axel – Department of Cardiology, University Clinic Tübingen | corimmun GmbH

Search results 71 to 80 from a total of 85